Lactate levels in Asian patients with type 2 diabetes mellitus on metformin and its association with dose of metformin and renal function

被引:0
|
作者
Lim, Vivien C. C.
Sum, C. F.
Lim, S. C.
Yeoh, Ly
Lee, Y. M.
Chan, Edwin S. Y.
Tey, B. H.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:A124 / A124
页数:1
相关论文
共 50 条
  • [21] Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function
    Janna K. Duong
    Shaun S. Kumar
    Carl M. Kirkpatrick
    Louise C. Greenup
    Manit Arora
    Toong C. Lee
    Peter Timmins
    Garry G. Graham
    Timothy J. Furlong
    Jerry R. Greenfield
    Kenneth M. Williams
    Richard O. Day
    Clinical Pharmacokinetics, 2013, 52 : 373 - 384
  • [22] Influence of duration and dose of metformin on cobalamin deficiency in type 2 diabetes patients using metformin
    Joline W. J. Beulens
    Huberta E. Hart
    Ron Kuijs
    Antoinette M. J. Kooijman-Buiting
    Guy E. H. M. Rutten
    Acta Diabetologica, 2015, 52 : 47 - 53
  • [23] Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus
    Fournier, Jean-Pascal
    Yin, Hui
    Yu, Oriana Hoi Yun
    Azoulay, Laurent
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2014, 186 (15) : 1138 - 1145
  • [24] Effects of metformin treatment on blood leptin and ghrelin levels in patients with type 2 diabetes mellitus
    Ida, Satoshi
    Murata, Kazuya
    Kaneko, Ryutaro
    JOURNAL OF DIABETES, 2017, 9 (05) : 526 - 535
  • [25] Effect of Metformin on Testosterone Levels in Male Patients With Type 2 Diabetes Mellitus Treated With Insulin
    Cai, Tingting
    Hu, Yun
    Ding, Bo
    Yan, Rengna
    Liu, Bingli
    Cai, Ling
    Jing, Ting
    Jiang, Lanlan
    Xie, Xiaojing
    Wang, Yuming
    Wang, Huiying
    Zhou, Yunting
    He, Ke
    Xu, Lan
    Chen, Liang
    Cheng, Cheng
    Ma, Jianhua
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] Renal Protective Effect of Metformin in Type 2 Diabetes Patients
    Wang, Hsi-Hao
    Lin, Sheng-Hsiang
    Hung, Shih-Yuan
    Chiou, Yuan-Yow
    Hsu, Wan-Chia
    Chang, Chih-Min
    Liou, Hung-Hsiang
    Chang, Min-Yu
    Ho, Li-Chun
    Wu, Ching-Fang
    Lee, Yi-Che
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [27] Daily insulin dose in combination with metformin or/and glimepiride in type 2 Diabetes Mellitus
    Kabadi, UM
    Kabadi, MM
    DIABETES, 2002, 51 : A102 - A102
  • [28] Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
    Tian Li
    Rui Providencia
    Nan Mu
    Yue Yin
    Mai Chen
    Yishi Wang
    Manling Liu
    Lu Yu
    Chunhu Gu
    Heng Ma
    Cardiovascular Diabetology, 20
  • [29] Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus
    Li, Tian
    Providencia, Rui
    Mu, Nan
    Yin, Yue
    Chen, Mai
    Wang, Yishi
    Liu, Manling
    Yu, Lu
    Gu, Chunhu
    Ma, Heng
    CARDIOVASCULAR DIABETOLOGY, 2021, 20 (01)
  • [30] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652